Hyperoxia-induced Converting Enzyme Insufficiency in Conscious Rat: Cardiovascular Effects

References

• Clark J M, Lambertson C J. Pulmonary oxygen toxicity: A review. Pharmacol Rev 1971; 23: 37–133
   PubMed Web of Science ®Google Scholar
• Fisher A B, Dodia C, Linask J. Perfusate composition and edema formation in isolated rat lungs. Exper Lung Res 1980; 1: 13–21
   PubMed Web of Science ®Google Scholar
• Kistler G S, Caldwell P RB, Weibel E R. Development of fine structural damage to alveolar and capillary lining cells in oxygen poisoned rat lungs. J Cell biol 1967; 32: 605–628
   PubMed Web of Science ®Google Scholar
• Block E R, Fisher A B. Hyperoxia and lung serotonin clearance: A new observation. Chest 71:Suppl 1977; 11: 289–291
   Google Scholar
• Block E R, Fisher A B. Depression of serotonin clearance by rat lungs during oxygen exposure. J Appl Physiol 1977; 42: 33–38
   PubMed Web of Science ®Google Scholar
• Dobuler K J, Catravas J D, Gillis C N. Early detection of oxygen-induced lung injury in conscious rabbits. Am Rev Respir Dis 1982; 126: 534–539
   PubMed Web of Science ®Google Scholar
• Toivoren H, Hartiala J, Bakhle Y S. Effects of high oxygen tension on the metabolism of vasoactive hormones in isolated perfused rat lungs. Acta Physiol Scand 1981; 111: 185–192
   PubMedGoogle Scholar
• Junod A F. Uptake, metabolism and efflux of 14C-5-hydroxytryptamine in isolated perfused rat lungs. J Pharmacol Exp Ther 1972; 183: 341–355
   PubMed Web of Science ®Google Scholar
• Cushman D W, Cheung H S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharm 1971; 20: 1637–1648
   PubMed Web of Science ®Google Scholar
• Lazo J S, Quinn D E. Solubilization of pulmonary angiotensin-converting enzyme with 1–0-n-Octyl-β-D-Glucopyrandoside. Anal Biochem 1980; 102: 68
   PubMed Web of Science ®Google Scholar
• Haber E, Koerner T, Page L B, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrinol 1969; 29: 1349–1355
   PubMed Web of Science ®Google Scholar
• Page L B, Haber E, Kimura A Y, Purnode A. Studies with the radioimmunoassay for angiotensin II and its application to the measurement of renin activity. J Clin Endocrinol 1969; 29: 200–206
   Web of Science ®Google Scholar
• Oparil S, Tregear G W, Koerner T, Barnes B A, Haber E. Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog. Circ Res 1971; 29: 682–690
   PubMed Web of Science ®Google Scholar
• Milnor W R, Jose A D. Distortion of indicator-dilution curves by sampling systems. J Appl Physiol 1960; 15: 177–180
   PubMed Web of Science ®Google Scholar
• Szelke M, Leckie B J, Tree M, Brown A, Grant J, Hallett A, Hughes M, Jones D M, Lever A F. H-77: A potent new renin inhibitor, in vivo and in vitro studies. Hypertension 1982; 4(Suppl II)II59–II69
   Google Scholar
• LaRochelle S T, Jr, North W G, Stern P. A new extraction of arginine vasopressin from blood: The use of octadecasilyl-silica. Pflug Arch 1980; 387: 79–81
   PubMed Web of Science ®Google Scholar
• Crofton J T, Share L, Want B C, Shade R E. Pressor responsiveness to vasopressin in the rat with DOCA-salt hypertension. Hypertension 1980; 2: 424–431
   PubMed Web of Science ®Google Scholar
• Statistical Methods, G W Snedecor, W G Cochran. The Iowa State University Press, Ames 1967
   Google Scholar
• Harabin A L, Homer L D, Bradley M E. Pulmonary oxygen toxicity in awake dogs: Metabolic and physiological effects. J Appl Physiol 1984; 57: 1480–1488
   PubMed Web of Science ®Google Scholar
• Krulewitz A H, Fanburg B L. The effect of oxygen tension on the in vitro production and release of angiotensin-converting enzyme by bovine pulmonary artery endothelial cells. Am Rev Respir Dis 1984; 130: 265
   Google Scholar
• Rubin D B, Housset B, Jean-Mairet Y, Junod A F. Effects of hyperoxia on biochemical indexes of pig aortic endothelial function. In Vitro 1983; 19: 625
   PubMedGoogle Scholar
• Bowman C M, Butler E N, Repin J E. Hyperoxia damages cultured endothelial cells causing increased neutrophil adherence. Am Rev Respir Dis 1983; 128: 469
   PubMed Web of Science ®Google Scholar
• Brunner H R, Gavras H, Waeber B, Kershaw G R, Turini G A, Gavras I. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med 1979; 90: 19–23
   PubMed Web of Science ®Google Scholar
• Mac Gregor G A, Markandu N D, Baylis J, Roulston J E, Squires M, Morton J J. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): Evidence for role of renin system in normotensive subjects. British Med J 1981; 283: 401–403
   PubMed Web of Science ®Google Scholar
• Abe Y, Okahar T, Kishimoto T, Yamamoto K. Intrarenal role of renin-angiotensin system in the regulation of renal hemodynamics. Jpn J Pharmacol 1979; 29: 325–333
   PubMedGoogle Scholar
• Boyd G W, Pearl W S. Angiotensin immunoassay. Handbook of Experimental Pharmacology. Angiotensin, I H Page, F M Bumpus. Springer-Verlag, New York 1974; 211–226
   Google Scholar
• Rosivall L, Rinder D F, Champion J, Khosla M C, Navar L G, Oparil S. Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog. Am J Physiol 1983; 245: F408–F415
   PubMed Web of Science ®Google Scholar
• Hollenberg N. Pharmacologic interruption of the renin-angiotensin system. Annu Rev Pharmacol Toxicol 1979; 19: 559
   PubMed Web of Science ®Google Scholar
• Oparil S. Angiotensin I converting enzyme inhibitors and analogs of angiotensin II. Hypertension: Physiopathology and Treatment, J Genest, O Kuchel, P Hamet, M Cantin. McGraw Hill, New York 1983; 250
   Google Scholar
• Oparil S, Horton R, Wilkins L H, Irvin J, Hammett D K, Dustan H P. Antihypertensive effect of enalapril (MK-421) in low renin essential hypertension: Role of vasodilator prostaglandins. Clin Res 1983; 31: 538A
   Google Scholar
• Vinci J M, Horowitz D, Zusman R M, Pisano J J, Catt K J, Keiser H R. The effect of converting enzyme inhibition with SW 20881 on plasma and urinary kinins, prostaglandin E and angiotensin II in hypertensive man. Hypertension 1979; 1: 416–426
   PubMed Web of Science ®Google Scholar
• Chiba S, Quilley C P, Mc Giff J C. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney. Hypertension 1982; 4(suppl II)II-80–II-85
   Google Scholar
• Crofton J T, Share L, Horovitz Z P. The effect of SQ 14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing SHR rat. Hypertension 1979; 1: 462
   PubMed Web of Science ®Google Scholar
• Mitchell H C, Pettinger W A, Gianotti L, Reed G, Kirk L, Kuhnert L, Matthews C, Anderson R. Further studies on the hypernoradrenergic state of treated hypertensives: Effect of captopril. Clin and Exper Hyper-Theory and Practice 1983; A5: 1611–1627
   Google Scholar
• Oparil S. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Cardiology Update. Elsevier Science Publishing Co., Inc., New York 1986, (in press)
   Google Scholar